JUNE 24, 2011 ~~~~~~~~~~~~~~~~~~~~~~~~~~
buttonabout buttonadvert buttonnetwork buttonmorealerts *
HOTM ) ~~~~~~~~~~~~~~~~~~~~~~~~~~
PRE-OPEN STOCK WATCH *************
S&P futures vs fair value: +1.40. Nasdaq futures vs fair value: -6.30.
Stock futures have ticked higher following a couple of solid pieces of data.
First quarter GDP was revised upward to reflect growth of 1.9%.
The consensus among economists surveyed by Briefing.com had called for GDP data to continue to reflect growth of 1.8%. Durable goods orders for May jumped 1.9%, which is greater than the 1.5% increase that had been widely anticipated.
Todays big news is that U.S. regulators rejected Thursday a tamper-resistant painkiller from Pfizer(PFE _ ) and Pain Therapeutics(PTIE _ ), said U.S. Food and Drug Administration spokesperson Shelly Burgess Thursday night.
The Pfizer-Pain Therapeutics drug, Remoxy, is a long-acting opioid consisting of the narcotic oxycodone mixed with ingredients aimed at making it resistant to abuse and misuse.
HOTM – CURRENTLY $0.44 BURBANK, CA–(Marketwire – 06/23/11) – HotCloud Mobile, Inc.
(OTC.BB:HOTM – News ), a vertically integrated wireless telecommunications company that operates three business units — products, services, and content — stated today that it has executed a strategic marketing agreement with NexBoom (TM) to promote 4D mobile app technology and bring co-branded apps to up to 100 million social media users.
HotCloud will use its distribution network and historic customer base to promote and market NexBoom`s tablet computer and provide a patented suite of co-branded mobile applications including a mobile platform to offer premium content.
HotCloud will also provide NexBoom with a customized mobile product insurance policy to offer its customers.
NexBoom will distribute and market HotCloud`s apps where appropriate to its network of up to 100M social media end users, and work with HotCloud to promote NexBoom`s tablet computer and technology.
ACUR – BACK ON THE MOVE ACUR – BREAKING $4.40 PRE-OPEN Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and manufacture of pharmaceutical product candidates utilizing its proprietary Aversion Technology, Impede Technology, and other technologies.
Its Aversion Technology is a proprietary platform technology providing abuse deterrent features and benefits to orally administered pharmaceutical drug products containing abusable active ingredients, such as tranquillizers, stimulants, sedatives, decongestants, and various other opioid analgesics.
DRRX – ACTIVITY WATCH DRRX – BREAKING $3 DURECT Corporation focuses on the development of pharmaceutical products for pain, central nervous system disorders, cardiovascular disease, and other chronic diseases based on its proprietary drug formulations and delivery platform technologies.
Its products include Remoxy, an oxycodone gelatin capsule for chronic pain, which is accepted as a new drug application…
hototclogo1 stlogo1 drstockpick pennystockdd VISIT qstockssmall ADVERTISEMENT / ALERT SERVICE ONLY Visit www.momentumtraders.net for more disclosure info …
NEVER – Make any Investment Decision based on any information produced in an e-mail newsletter and / or website or any other media format…
ALWAYS – Do your own homework and make Investment Decisions carefully and after personal due diligence.
MomentumTraders.net is a subscription based Internet Forum for our members to participate through e-mails to bring stock market activity to the attention of the entire membership.
MomentumTraders.net does accept advertisement fees for distribution of corporate information to our membership. The paid advertisements often fall under the category of a Company Spotlight. The paid advertisements almost entirely consist of small OTCBB and Pink Sheet Companies and therefore fall under the category of High Risk Potential.
The Information contained within this Web site, e-mail transmissions, faxes, and recorded voice messages (hereinafter collectively referred to as “Information”) are not solicitations to buy, sell, or hold any securities mentioned.
BE AWARE Assume that the information about these companies is not trustworthy unless you can prove otherwise through your own independent research.
The Information should not be used as the sole basis for making any investment decision.
Readers are urged to make a complete review of the companies mentioned, which should include, but is not limited to, each company`s quarterly and annual reports, all SEC filings, and press releases.
The information in this newsletter/website should be viewed just as you would view a television commercial or a magazine ad… This is NOT the place to make investment decisions, NEVER buy or sell stocks based on any newsletter or website information sheet etc…
Readers should do their own due diligence prior to investing in any securities.
MomentumTraders.net is NOT a registered investment advisor or a broker dealer and is not selling investment advice.
Estimates, assumptions and other forward-looking Information are subject to the limits of forecasting. Actual future developments may differ due to many factors.
BE AWARE that many companies within these newsletters have considerable ongoing concern issues and may be in dire straights due to lack of funding… These companies may be on the verge of delisting, bankruptcy and worse.
BE AWARE… Often times, small and thinly traded companies will hire large groups of investment newsletters in order to increase their exposure and daily volumes in order to facilitate selling and/or to raise capital… Often times, these large investment newsletters are paid with large blocks of free trading shares and will increase the risks of dilution and heavy selling/price loss of the small and thinly traded company.
MomentumTraders.net derives its revenues from banner advertising and membership fees for the momentum alert service, as well as from Corporate Profiles and Consulting Programs, and does with full disclosure accept gifts, promotional items, and or compensation from companies that are profiled or mentioned.
MomentumTraders.net and its affiliates WILL buy, sell, and hold stock received from third parties as compensation for representing client companies, This should be viewed as a conflict of interest and all alerts should be viewed as commercial advertisement and NOT as any type of investment information.
MomentumTraders.net has received compensation from third parties and or companies for consulting information for the following stocks.
MomentumTraders.net has no relationship with any third parties and or companies other than as an advertisement consulting business to advertisement consulting client relationship.
All companies who pay MomentumTraders.net with shares of stock do so with agreement that by the act of advertising and or consulting with us that any equity based compensation under the Agreement is not and shall not be the result of issuance of shares under Form S-8 or other similar registration and that such compensation has been fully paid and is non-assessable.
MomentumTraders.net reserves the right to trade in any securities mentioned within e-mails and on site.
MomentumTraders.net may buy and sell securities at any time before, during or after being placed in e-mail or on website.
All Information, including any analysis or opinion, is believed to be reliable, and is presented in good faith; but no representation or warranty, expressed or implied, is made as to its accuracy, completeness, or correctness.
BE AWARE…Often times, newsletters may add content to suggest revenue increases, income projections, contract expansions and other projected positive developments…This often is not based in fact, and often is misleading.
MomentumTraders.net is not responsible for any content that may be issued from newsletters that we may outsource for distribution of press releases and information sheets etc, on any company.
MomentumTraders.net is not responsible for any claims made by any companies profiled.
The recipient of any Information should understand that changes may occur in the affairs of companies profiled since the date of profiling.
We reserve the right to make improvements to, or correct any content, omissions, or errors without notice.
MomentumTraders.net is not liable for any losses or damages, monetary or otherwise, which may result from the content of the Information.